Sushmita Banerjee1, Nivedita Kamath2, Sampson Antwi3, Melvin Bonilla-Felix4. 1. Calcutta Medical Research Institute, Kolkata, India. sushmitabanerj@gmail.com. 2. St John's Medical College Hospital, Bangalore, India. 3. Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 4. University of Puerto Rico-Medical Sciences Campus, San Juan, Puerto Rico.
Abstract
BACKGROUND: Nearly 50% of the world population and 60% of children aged 0 to 14 years live in low- or lower-middle-income countries. Paediatric nephrology (PN) in these countries is not a priority for allocation of limited health resources. This article explores advancements made and persisting limitations in providing optimal PN services to children in such under-resourced areas (URA). METHODS: Medline, PubMed and Google Scholar online databases were searched for articles pertaining to PN disease epidemiology, outcome, availability of services and infrastructure in URA. The ISN and IPNA offices were contacted for data, and two online questionnaire surveys of IPNA membership performed. Regional IPNA members were contacted for further detailed information. RESULTS: There is a scarcity of published data from URA; where available, prevalence of PN diseases, managements and outcomes are often reported to be different from high income regions. Deficiencies in human resources, fluoroscopy, nuclear imaging, immunofluorescence, electron microscopy and genetic studies were identified. Several drugs and maintenance kidney replacement therapy are inaccessible to the majority of patients. Despite these issues, regional efforts with support from international bodies have led to significant advances in PN services and infrastructure in many URA. CONCLUSIONS: Equitable distribution and affordability of PN services remain major challenges in URA. The drive towards acquisition of regional data, advocacy to local government and non-government agencies and partnership with international support bodies needs to be continued. The aim is to optimise and achieve global parity in PN training, investigations and treatments, initially focusing on preventable and reversible conditions.
BACKGROUND: Nearly 50% of the world population and 60% of children aged 0 to 14 years live in low- or lower-middle-income countries. Paediatric nephrology (PN) in these countries is not a priority for allocation of limited health resources. This article explores advancements made and persisting limitations in providing optimal PN services to children in such under-resourced areas (URA). METHODS: Medline, PubMed and Google Scholar online databases were searched for articles pertaining to PN disease epidemiology, outcome, availability of services and infrastructure in URA. The ISN and IPNA offices were contacted for data, and two online questionnaire surveys of IPNA membership performed. Regional IPNA members were contacted for further detailed information. RESULTS: There is a scarcity of published data from URA; where available, prevalence of PN diseases, managements and outcomes are often reported to be different from high income regions. Deficiencies in human resources, fluoroscopy, nuclear imaging, immunofluorescence, electron microscopy and genetic studies were identified. Several drugs and maintenance kidney replacement therapy are inaccessible to the majority of patients. Despite these issues, regional efforts with support from international bodies have led to significant advances in PN services and infrastructure in many URA. CONCLUSIONS: Equitable distribution and affordability of PN services remain major challenges in URA. The drive towards acquisition of regional data, advocacy to local government and non-government agencies and partnership with international support bodies needs to be continued. The aim is to optimise and achieve global parity in PN training, investigations and treatments, initially focusing on preventable and reversible conditions.
Authors: William E Smoyer; Fredric O Finkelstein; Mignon I McCulloch; Mary Carter; Ariane Brusselmans; John Feehally Journal: Kidney Int Date: 2016-02 Impact factor: 10.612
Authors: Wasiu A Olowu; Abdou Niang; Charlotte Osafo; Gloria Ashuntantang; Fatiu A Arogundade; John Porter; Saraladevi Naicker; Valerie A Luyckx Journal: Lancet Glob Health Date: 2016-04 Impact factor: 26.763
Authors: Scott M Sutherland; Jun Ji; Farnoosh H Sheikhi; Eric Widen; Lu Tian; Steven R Alexander; Xuefeng B Ling Journal: Clin J Am Soc Nephrol Date: 2013-07-05 Impact factor: 8.237